Equation for Calculating Free Fraction of Drugs
Estimate unbound drug fraction (fu), bound fraction (fb), and unbound concentration with clinically useful equations.
Interactive Free Fraction Calculator
Free vs Bound Distribution
Expert Guide: Equation for Calculating Free Fraction of Drugs
In clinical pharmacology, the free fraction of a drug, usually written as fu, is one of the most important parameters for understanding response, toxicity risk, dose adjustment, and interpretation of therapeutic drug monitoring. A total plasma drug concentration can look normal while the free concentration is clinically high, especially when albumin is reduced, alpha-1 acid glycoprotein changes during inflammation, or protein binding is displaced by another medication. That is why people search for a reliable equation for calculating free fraction of drugs in practice settings ranging from ICU care to research pharmacokinetics.
The core principle is simple: only unbound drug can freely diffuse across membranes, interact with most receptors, and be cleared by glomerular filtration. The bound fraction acts more like a reservoir. However, in real patients, this reservoir shifts with disease, age, protein concentrations, and co-administered drugs. The equations below help you quantify those shifts instead of relying on rough assumptions.
Core Equations You Should Know
- Free fraction from concentrations: fu = Cu / Ct
- Bound fraction: fb = Cb / Ct = 1 – fu
- Unbound concentration from total: Cu = fu x Ct
- Single-site binding model: fu = 1 / (1 + Ka x [P])
- Multi-site approximation: fu = 1 / (1 + n x Ka x [P])
Where Ct is total concentration, Cu is unbound concentration, Cb is bound concentration, Ka is association constant, [P] is protein concentration, and n is the number of effective independent sites. The concentration-based formula is ideal when you have measured values. The binding-constant formula is useful in simulations, early development, and situations where direct unbound assays are unavailable.
Why Free Fraction Matters More Than Total Concentration in Many Cases
Total concentration is easy to measure and often used for standard therapeutic ranges, but it can mislead when protein binding changes. Consider a highly protein-bound drug such as warfarin or diazepam. A small absolute change in binding can produce a relatively large percentage change in free concentration. For narrow-therapeutic-index drugs, that difference can be clinically meaningful.
In addition, disease states alter binding proteins. Albumin can decline in chronic liver disease, nephrotic syndrome, burns, cancer, and severe critical illness. Alpha-1 acid glycoprotein can rise during inflammatory states and trauma, increasing binding for many basic drugs. Pregnancy, aging, and uremic toxins also influence protein binding. This is exactly where free-fraction equations become essential for interpretation and for pharmacokinetic modeling.
How to Use the Equation in Day-to-Day Clinical Interpretation
- Measure or estimate total concentration (Ct).
- If available, obtain bound concentration (Cb) or direct unbound concentration (Cu).
- Calculate fu = (Ct – Cb) / Ct when Cb is known.
- Calculate Cu = fu x Ct and compare with unbound therapeutic targets when available.
- Review patient factors that can alter binding: albumin, inflammation, renal function, liver function, interacting drugs.
This workflow improves dosing precision, especially in ICU and complex polypharmacy settings. It also helps explain apparent discrepancies between clinical effect and total measured concentration.
Comparison Table: Typical Human Plasma Protein Levels Relevant to Drug Binding
| Protein | Typical Adult Plasma Range | Major Drug Binding Pattern | Clinical Impact When Altered |
|---|---|---|---|
| Albumin | 35 to 50 g/L | Primarily acidic and neutral drugs | Low albumin often increases fu for highly albumin-bound drugs |
| Alpha-1 acid glycoprotein | 0.5 to 1.2 g/L (can rise 2 to 5 times in inflammation) | Many basic drugs | Acute phase response may reduce fu for basic compounds |
| Lipoproteins | Variable by lipid profile and disease state | Highly lipophilic compounds | Can alter distribution and apparent fu in dyslipidemia |
These ranges are widely reported in clinical chemistry and pharmacology references and are central to interpreting free-fraction changes. Protein concentrations should always be interpreted with the patient context, not as static values.
Comparison Table: Example Drug Binding Statistics and Practical Interpretation
| Drug | Approximate Plasma Protein Binding | Estimated fu | Practical Clinical Interpretation |
|---|---|---|---|
| Warfarin | About 99% | About 0.01 | Very small binding changes can noticeably alter active concentration |
| Phenytoin | About 90% | About 0.10 | Low albumin can increase free phenytoin despite normal total level |
| Diazepam | About 98 to 99% | About 0.01 to 0.02 | High binding means free level shifts may matter during illness or aging |
| Valproate | About 80 to 95% (concentration dependent) | About 0.05 to 0.20 | Nonlinear binding can increase fu at higher concentrations |
| Gentamicin | Less than 30% | Greater than 0.70 | Low binding means total concentration often tracks active fraction better |
These values are representative ranges reported in drug labeling and pharmacology references. Exact percentages vary by assay conditions, patient population, and concentration range. Use local lab standards when available.
Important Model Assumptions and Where They Fail
1) Linear, single-site assumptions
The equation fu = 1 / (1 + Ka x [P]) assumes a simple one-site interaction with no saturation in the concentration range studied. Real biology can involve multiple proteins and concentration-dependent affinity. That means the equation is highly useful as a first-order estimate, but not always sufficient for every molecule.
2) Saturable binding
For drugs with saturable protein binding, fu may increase as total concentration rises. Valproate is a classic example where unbound fraction can increase substantially at higher concentrations. In these cases, direct unbound measurements provide better decision support than a fixed fu assumption.
3) Competitive displacement and disease effects
Other drugs, endogenous substances, or disease-related molecules can displace binding. Uremic toxins and bilirubin can alter binding behavior. Because of this, a textbook fu can differ significantly from an ICU patient fu measured at the bedside.
Step-by-Step Numerical Example
Suppose Ct = 12 mg/L and measured Cb = 10.8 mg/L.
- Calculate Cu = Ct – Cb = 1.2 mg/L
- Calculate fu = Cu / Ct = 1.2 / 12 = 0.10
- Bound fraction fb = 1 – fu = 0.90
- Interpretation: 10% of drug is free, 90% bound
If the same patient later develops hypoalbuminemia and fu rises to 0.18 while total Ct remains around 12 mg/L, then Cu becomes 2.16 mg/L. The total concentration appears unchanged, but pharmacologically active concentration increased by 80%. This is precisely why free-fraction equations and free level monitoring matter.
How to Integrate Free Fraction into Dosing Decisions
- Prioritize unbound levels for highly protein-bound, narrow therapeutic index drugs when available.
- When only total levels are available, use estimated fu carefully and reassess after major clinical changes.
- Recalculate fu when albumin, renal status, inflammatory markers, or interacting medications change.
- Document the equation and assumptions used so interpretation remains reproducible.
Regulatory and Academic References for Deeper Reading
For readers who want source-level guidance and background, the following references are useful:
- U.S. Food and Drug Administration (FDA): Clinical Pharmacology resources
- U.S. National Library of Medicine (NIH/NLM): Drug disposition and pharmacokinetics textbooks
- MedlinePlus (.gov): Albumin test interpretation
Final Practical Takeaway
The equation for calculating free fraction of drugs is not just a classroom formula. It is a practical clinical tool that helps bridge pharmacokinetics and real patient care. Use concentration-based equations whenever measured values are available, apply binding-constant equations for estimation and modeling, and always interpret results in light of patient physiology. In high-risk medications, small shifts in fu can drive major differences in effect. A structured calculator and consistent interpretation workflow can significantly improve decision quality.